A new study published in JAMA (Journal of the American Medical Association) has found that daily multivitamin supplementation may help reduce the risk of total cancer in middle aged and older healthy men. The results of the study showed a modest reduction in total cancer, however, there was no statistically significant reduction in prostate, colorectal, lung or bladder cancers.
The multivitamin and cancer arm of the Physicians’ Health Study (PHS) II, the only large-scale, randomized, double-blind, placebo-controlled trial (RCT) to study the long-term effects of a multivitamin in chronic disease, was conducted by researchers at Brigham and Women’s Hospital and Harvard Medical School. PHS II studied nearly 15,000 male U.S. physicians aged 50 years and older for over a decade.
According to the Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement industry, the well-designed study provides encouraging news, particularly for healthy men looking to remain healthy.